The UCSF Center for Genome Surgery is a partnership between the UCSF Broad Stem Cell Center and the Innovative Genomics Institute, established to bring curative genomic therapies to people with well-defined genetic disorders.

At present, our work is to build the clinical and preclinical infrastructure that is essential to implement genomic technologies in our hospitals. Infrastructure that includes:

The CGS Interventional Genomics Case Conference reviews patients with well-defined, monogenetic disorders that may be candidates for novel precision medicine therapies.
  • Governance to ensure all critical scientific, clinical, ethical, and safety considerations are reviewed and addressed
  • Interdisciplinary case review to identify patients
  • Expert clinical teams to provide complex, cross-disciplinary care
  • Expert preclinical research teams that develop and validate patient-specific therapies
  • Industry partnerships to manufacture patient-grade products

The Center for Genome Surgery will provide an integrated clinical and research pathway that connects clinical diagnosis, scientific discovery, therapeutic development, and clinical implementation.
 

 

UCSF Broad Stem Cell Center logo, featuring four curved teal lines beside the words ‘UCSF Broad Stem Cell Center’ in gray and blue.
UCSF Center for Genomic Sciences logo featuring a stylized blue DNA double helix encircled by light blue curves, with the UCSF name below.
Innovative Genomics Institute logo, featuring a purple geometric DNA-inspired symbol beside the words ‘Innovative Genomics Institute’ in black.